Company intelligence / Profile preview

Suttons Creek

United States

Ownership: Private
Development stage: Other

Overview

Suttons Creek does not develop its own clinical products but has supported the successful development and launch of over 120 drug and biologic delivery systems for pharmaceutical and biotech clients, including auto-injectors and prefilled syringes[1][2].

Modalities: DeviceDrug delivery systemBiologic delivery deviceSmall molecule delivery deviceAuto injectorPrefilled syringe
Industry: Consulting

Partnerships

BlueRidge Life Sciences

Beyond the preview

Go deeper on Suttons Creek.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Suttons Creek.

Explore the full profile